Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Dobesilate vs Flavonoids in Early Hemorrhoidal Disease
NCT02782455Phase 4Completed
- Sponsor
- Services Hospital Lahore
- Start
- Dec 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of calcium dobesilate in Hemorrhoids (2 arms), sponsored by Services Hospital Lahore. Primary endpoint: Frequency of occurrence of rectal bleeding after usage of drug at 1 week. Started Dec 2016; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT02782455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782455.